Risk Evaluation and Mitigation Strategy (REMS)
OBJECTIVES
This course gives you an introduction to :
-
REMS principles, content, implementation, reporting and assessment
-
When a REMS is required
-
Differences between REMS and RMP
It provides examples of REMS that have been implemented to reduce patients’ risk from their medications.
REMS, principles, content, implementation, reporting, assessment, RMP, FDA
LEARNING OUTCOMES
At the end of the course, you will :
Understand how REMS are useful tools to reduce risk to patients from their medication
Know when FDA requires REMS
Know when REMS are tailored to the specific risk and can include one or more specified elements
Know when sponsors must report periodically to FDA on REMS effectiveness
|
|
135 minutes |
|
Online based learning |
|
English language |
|
Certificate of Achievement |
|
225 € / $240 |
REGISTER NOW
|
|
AUTHORS
|
Dr. John Price
Pharmaceutical physician consultant, patient safety, pharmacovigilance and regulatory affairs Independent
|
|
Nasop Experts Group
ISoP's North American chapter
|
This short course has been added to your Study List:
Risk Evaluation and Mitigation Strategy (REMS)
Please note that this short course is currently in update.
It will be available within 15 working days.
This short course has been added to your Study List:
Risk Evaluation and Mitigation Strategy (REMS)
COMPANIES OFFER
Short courses can be included in a training package for your team!
NEED TO TALK TO US?
+33 5 47 30 42 69
Monday-Friday / 9.00am-6.00pm CET